SCHEMBL2638236

SCHEMBL2638236

Cc1cc(S(=O)(=O)NC(=O)[C@@H](N)C(C)C)ccc1NC(=O)Cc1ccc(Cl)c(Oc2cc(Cl)cc(C#N)c2)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.39
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RORC P51449 4/20 0.34
SLC22A12 Q96S37 1/20 0.34
EPAS1 Q99814 1/20 0.33
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
PIK3CG P48736 1/20 0.31
TARS1 P26639 1/20 0.31
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30
BCL2 P10415 1/20 0.30
MCL1 Q07820 1/20 0.30
SLC2A1 P11166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2641329 1.00 CYP3A4 (0.39) CYP3A4CYP2C9CYP2C19RORCSLC22A12
SCHEMBL2640997 0.94 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19RORCSLC22A12
SCHEMBL2637922 0.94 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19RORCSLC22A12
SCHEMBL3833330 0.94 CYP3A4 (0.42) CYP3A4CYP2C9CYP2C19RORCSLC22A12
SCHEMBL2638996 0.89 CYP3A4 (0.42) CYP3A4CYP2C9CYP2C19RORCSLC22A12
SCHEMBL5169997 0.88 CYP3A4 (0.39) CYP3A4CYP2C9CYP2C19RORCSLC22A12
SCHEMBL5170005 0.88 CYP3A4 (0.39) CYP3A4CYP2C9CYP2C19RORCSLC22A12
SCHEMBL3833407 0.88 CYP3A4 (0.42) CYP3A4CYP2C9CYP2C19RORCSLC22A12
SCHEMBL2638934 0.88 CYP3A4 (0.45) CYP3A4CYP2C9CYP2C19RORCSLC22A12
SCHEMBL3833331 0.87 CYP3A4 (0.41) CYP3A4CYP2C9CYP2C19RORCSLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4810529-B2 2011-11-09 JP claimed
EP-1742908-B1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2009-11-11 EP claimed
EP-1742908-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2007-01-17 EP claimed
WO-2005102989-A1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2005-11-03 WO claimed
EP-1742908-B1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2009-11-11 EP disclosed